黄芪、参麦注射液联合应用治疗小儿病毒性心肌炎疗效观察

目的:观察黄芪注射液联合参麦注射液治疗小儿病毒性心肌炎的疗效。方法:将94例病毒性心肌炎患儿按治疗方式不同随机分为对照组40例和观察组54例,对照组给予常规治疗,观察组在对照组基础上加用黄芪注射液和参麦注射液治疗,观察两组治疗后疗效。结果:观察组临床疗效和心电图改善均明显优于对照组(P<0.05);两组治疗后心肌酶谱均较治疗前有明显下降,且观察组改善更显著(P<0.05);观察组体征、临床症状、心电图及心肌酶恢复时间均显著优于对照组(P<0.05)。结论:黄芪注射液联合参麦注射液治疗小儿病毒性心肌炎可提高患儿的疗效,缩短病程,且不良反应少,值得推广应用。

Clinical observation on treating VMC in children with injection

Objective： To observe the clinical effect of Huangqi injection combined with Shenmai injection on treating VMC in children. Methods： 94 patients with VMC were randomly divided into control group （40 cases） and observation group （54 cases）. The control group received conventional treatment, while patients of observation group received Huangqi injection combined with Shenmai injection on the basis of control group and evaluate the clinical efficacy of two groups. Results： Compared to control group, the therapeutic effect and electrocardiogram amelioration of the observation group increased significantly （P〈0.05）. After treatment, myocardial enzymes of observation group had significant differences compared with control group （P〈0.05）. The recovery time of clinical objective, symptom, electrocardiogram and myocardial enzymes were shorter than that in the control group （P〈0.05）. Conclusion： Huangqi injection combined with Shenmai injection on treating VMC in children can improve the curative effect, shorten the course of disease, and is safe and worthy of clinical application.